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INTRODUCTION
Several German cockroach allergens, which stimulate IgE pro-
duction and cause IgE-mediated diseases, have been identified.
Bla g 4 is a species-specific allergen produced by Blatella germani-
ca [1] and expressed in a sex-specific manner in the reproduc-
tive system of adult male German cockroaches. It is associated
with the spermatophore, transferred to the female during cop-
ulation and developmentally regulated by juvenile hormones
[2]. Although the sequence identity between Bla g 4 and lipo-
calins is low (19-24%), it contains the structurally conserved
regions (SCR) of lipocalin [3]. Structural homology between
other allergenic lipocalins (Rat n 1, Can f 1, Can f 2, Bos d 2,
Bos d 5, Equ c 1, and Equ c 2) is known to be high [4]. The struc-
tural model shows it to be cup-shaped with 8 strands and an
anti-parallel β‚ barrel shape [5]. Higher expression yields of Bla
g 4 can be obtained in Pichia pastoris than in Escherichia coli [6].
Accordingly, Bla g 4 warrants further investigation for its role in
causing inflammation in patients with asthma.
Recombinant allergens for immunotherapy may be used to
alter immune responses or to reduce the allergenic activity of
other allergens. Genetically modified recombinant allergens
provide several advantages [7]. These molecules preserve the
repertoire of allergen-specific T-cell epitopes and could inhibit
the binding of allergic patients’ IgE antibodies to allergens rep-
resented by the mutagenesis of B-cell epitopes [8]. Specially,
hypoallergens with reduced allergenic activity could be obtained
by site-directed mutagenesis when the information on IgE bind-
ing epitopes is available. These studies are useful for designing
of specific immunotherapy. Previously, we have investigated
the sequence polymorphisms of Bla g 4 [9]. Furthermore, the
sequence diversity of Bla g 4 was found to be produced by the
post-transcriptional modification [10].
Although Bla g 4 is a major allergen, IgE binding epitopes
have not been investigated. We are thus compelled to examine
their allergenicity of recombinant Bla g 4 fragments. 
MATERIALS AND METHODS
Patient sera
A total of 48 sera was included in this study. Thirty-two cock-
roach-allergic patients and 16 healthy individuals without cock-
roach allergies were recruited, and their sera were studied. The
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allergic patients (n = 32, ages ranging from 7 to 58 year) attended
the Allergy Clinic of Severance Hospital, Yonsei University College
of Medicine, Seoul, Korea. All sera were confirmed for the pres-
ence of IgE antibodies > 0.7 kU/L against B. germanica using the
Uni-CAP system (Amersham Pharmacia Biotech, Little Chalfont,
UK). Table 1 shows the characteristics of the 32 allergic patients. 
Cockroaches
Colonies of German cockroaches, B. germanica, have been
maintained in the insect rearing facility of the Korea National
Arthropods of Medical Importance Resource Bank, Department
of Environmental Medical Biology, Yonsei University College of
Medicine, Seoul, Korea. Mouse food was used as a diet. Cockro-
aches were collected after anesthetized with carbon dioxide gas
and kept at -70℃ until use.
Molecular cloning of Bla g 4 cDNA
Total RNA was isolated from 6 adult B. germanica males using
the Trizol reagent (Invitrogen, Carsbad, California, USA) accord-
ing to manufacturer’s instructions. A cDNA encoding Bla g 4
was obtained by reverse transcriptase-PCR (RT-PCR) as described
previously [9]. Primer sequences used for the PCR are as follows:
Bg4F (5′-GCAGTTTTGGCACTATGTGC-3′and Bg4R (5′CTTA-
GTGACATGTGGAGTG-3′). PCR was performed with 35 cycles
of 30 sec at 94℃, 30 sec at 50℃, and 1 min at 72℃ in a volume
of 50 μL. An initial 5-min incubation at 95℃ was performed,
along with a final extension of 9 min at 72℃. The PCR ampli-
fied products were ligated into the pGEM-T Easy vector (Pro-
mega, Madison, Wisconsin, USA) and transformed into com-
petent E. coli JM109. 
Sequence analysis and database search
Sequence alignments and database homology searches, mul-
tiple sequence alignments were performed using the BioEdit
(www.Mbio.ncsu.edu/BioEdit) and CLUSTAL X programs (ftp://
ftp-igbmc.u-strasbg.fr/pub/ClustalX). Comparison of amino
acid sequences was carried out at the NCBI site using the BLAST
network service. 
Expression and construction of Bla g 4 peptide fragments
To express the recombinant Bla g 4 in E. coli, the full-length
Bla g 4 cDNA was amplified from pGEM-T Easy-Bla g 4. Bla g 4
(EF202172) [9] was divided into 5 overlapping peptide frag-
ments (E1: aa 1-100, E2: aa 34-77, E3: aa 74-117, E4: aa 114-156,
and E5: aa 153-182) (Fig. 1). The specific primers used in PCR
are listed in Table 2. PCR was carried out with an annealing tem-
perature of 52℃. The amplified PCR products were ligated into
pET-28b (Novagen, Madison, Wisconsin, USA) using BamHI and
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Serum
sample
Sexa
Age
(year)
Diagnosis  OD450b
P1 M 43 Allergic asthma 0.0795
P2 F 52 Dermatofibroma 0.0855
P3 F 45 Allergic rhinitis 0.0730
P4 F 57 Allergic asthma 0.0725
P5 F 46 Allergic rhinitis 0.0745
P6 M 49 Allergic asthma 0.0770
P7 F 22 Atopic dermatitis 0.0785
P8 M 35 Allergic rhinitis 0.0740
P9 M 49 Allergic asthma 0.0890C
P10 M 48 Allergic asthma 0.0865
P11 M 11 Atopic dermatitis 0.2155
P12 F 45 Allergic asthma 0.0900
P13 M 26 Atopic dermatitis 0.0790
P14 M 45 Allergic rhinitis 0.0910
P15 M 56 Allergic asthma 0.0860
P16 M 47 Atopic dermatitis 0.1635
P17 F 37 Allergic asthma 0.0800
P18 F 58 Allergic asthma 0.0795
P19 M 52 Allergic asthma 0.0725
P20 M 38 Allergic rhinitis 0.0765
P21 M 26 Allergic asthma 0.0725
P22 M 33 Allergic rhinitis 0.0835
P23 F 17 Atopic dermatitis 0.0825
P24 F 36 Allergic asthma 0.0730
P25 M 30 Allergic rhinitis 0.0730
P26 M 7 Atopic dermatitis 0.0810
P27 M 20 Allergic asthma 0.0725
P28 M 24 Allergic asthma 0.1030
P29 M 41 Allergic asthma 0.0680
P30 M 14 Atopic dermatitis 0.0690
P31 F 15 Atopic dermatitis 0.1045
P32 M 53 Allergic rhinitis 0.0680
Table 1. IgE reactivity of human sera against recombinant Bla g 4
aM, male; F, female; bThe cut-off value is 0.086419; CPositives are indi-
cated by underlines.
Oligonucleotides Sequencesa
Bg4 -E1F 5′-GGATCCGGCAGTTTTGGCACTA-3′
Bg4 -E1R 5′-CTCGAGGTGCTGTATCATTTCT-3′
Bg4 -E2F 5′-GGATCCGTGGATTATTGCAGCC-3′
Bg4 -E2R 5′-CTCGAGTCTTATAGCAGTCTTA-3′
Bg4 -E3F 5′-GGATCCGGCTATAAGAGGACGA-3′
Bg4 -E3R 5′-CTCGAGGCCTTCCACAATTGCG-3′
Bg4 -E4F 5′-GGATCCAGTGGAAGGCTGTCCC-3′
Bg4 -E4R 5′-CTCGAGCACCTGATCCAAAGTG-3′
Bg4 -E5F 5′-GGATCCGGATCAGGTGAATCAA-3′
Bg4 -E5R 5′-CTCGAGTTAGTTACATGTGGAG-3′
Table 2. Sequences of oligonucleotides used for the production
of fragments of Bla g 4
aUnderline indicates restriction enzyme sites.
XhoI restriction sites and transformed into E. coli BL21 (DE3). 
For protein expression, the full-length and peptide fragments
of Bla g 4 were over-expressed in E. coli BL21 (DE3). A single
colony from the positive clones was inoculated into 10 mL of
Luria Bertani broth, and cultures were grown overnight at 37℃
with shaking. After 16 hr, the culture was further diluted into 1 L
and cultured at 37℃with vigorous shaking (210 rpm) until the
OD600 reached 0.6, when isopropyl-1-thio-β-galactopyranoside
(IPTG) was added to a final concentration of 1 mM to induce
expression. After 4 hr, the cells were harvested by centrifugation at
3,000 g for 20 min. The pellets of the full-length and peptide
fragments (E1, E2, and E4) were resuspended in 20 mM Tris, 500
mM NaCl, 5 mM imidazole, and 6 M urea, pH 7.9, and sonicat-
ed for 6 × 10 sec with 10 sec pause at 250 W. The pellets exp-
ressing peptide fragments (E3 and E5) were resuspended in 10
mM imidazole, 300 mM NaCl, 50 mM NaH2PO4 at pH 8.0 and
lysed using a sonicator. Recombinant proteins were purified by
using nickel-nitrilotriacetic acid resin (QIAGEN, Valencia, Cali-
fornia, USA) according to the manufacturer’s instructions under
native conditions or denaturing conditions. Purified recombinant
proteins were separated on 18% polyacrylamide gels contain-
ing sodium dodecyl sulfate (SDS) under denaturing conditions
and visualized by Coomassie brilliant blue.
IgE binding reactivity and IgE epitope analysis of 
recombinant Bla g 4
Purified recombinant Bla g 4 was diluted to 10 μg/ml in a
coating buffer (0.1 M sodium carbonate, pH 9.6). Each well of
a 96-well microplate was coated with 100 μl of the recombi-
nant protein and incubated at 4℃ overnight, followed by wash-
ing with phosphate-buffered saline (pH 7.4) containing 0.05%
Tween 20 (PBST). For the blocking, 200 μl of blocking solution
(3% w/v skim milk in PBS) was added individually and the plate
was further incubated at room temperature (RT) for 1 hr. Human
serum samples (1 : 4 dilutions) were then added and incubat-
ed for 2 hr. The wells were washed as previously described. Fifty
microliters of biotinylated goat anti-human IgE (1 : 1,000 dilu-
tion) (Vector, Burlingame, California, USA) were added to each
well and incubated for 1 hr at RT. After washing with PBST, 50
μl of streptavidin-peroxidase (Sigma, St. Louis, Missouri, USA)
diluted 1 : 1,000 in the diluent buffer was added to each well and
incubated for 30 min. The color was developed using 3,3′,5,5′-
tetramethyl-benzidine (TMB, Kirkegaard & Perry Laboratories,
Gaithersburg, Maryland, USA) as a substrate solution. The plate
was kept in the dark for 20 min and the reaction stopped by
addition of 100 μl of 0.5 M H2SO4. The absorbance was deter-
mined at 450 nm with the automatic microplate reader (TECAN,
Salzburg, Austria). The mean absorbance level plus 2 standard
deviations of 16 healthy controls was used as a cut-off value.
IgE binding reactivities of the peptide fragments were mea-
sured by ELISA using 4 sera samples obtained from recombi-
nant Bla g 4 positive sera. Purified recombinant peptide frag-
ments (10 μg/ml) in a coating buffer (0.1 M sodium carbon-
ate, pH 9.6) were coated into each well of the microtiter plate
and ELISA was performed as described above. The cut-off value
was the absorbance level plus 2 standard deviations of 4 healthy
controls. Each determination was done in duplicate.
RESULTS
Expression of recombinant Bla g 4 and peptide fragments
Full-length and peptide fragments containing BamHI-XhoI
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Fig. 1. (A) Schematic representation of Bla g 4 fragments for epitope analysis. (B) SDS-PAGE of full-length and peptide fragments. Proteins
run on 5-20% gradient SDS-PAGE gel and stained with Coomassie brilliant blue. M, Molecular weight markers in kDa; F, full-length; E1, 1-
100 amino acid; E2, 34-77; E3, 74-117; E4, 114-156; and E5, 153-182. 
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restriction sites were subcloned into the pET-28b expression
vector. The recombinant proteins were expressed as N-terminal
fusion proteins with 6 histidine residues. The full-length and
fragments 1, 2, and 4 were obtained from an insoluble fraction,
while fragments 3 and 5 were obtained from a soluble fraction
(Fig. 1A). The protein yield was 2.07 mg/L as measured by the
Bradford assay (Bio-rad, Hercules, California, USA). The full-
length protein purified by Ni-nitrilotriacetic acid-agarose migrat-
ed as a single band with a molecular weight of about 24 kDa.
Peptide fragments migrated at molecular weights higher than
their predicted sizes on a 5-20% gradient SDS gel (Invitrogen)
(Fig. 1B).
IgE-binding reactivity of recombinant Bla g 4
The purified recombinant Bla g 4 was tested for its reactivity
with IgE antibodies by ELISA in 32 sera from German cock-
roach-sensitized patients. Among the 32 sera tested, 25% exhib-
ited IgE reactivity to recombinant Bla g 4 (Fig. 2). Healthy human
sera used as the negative control did not show any IgE reactivity.
Determination of the IgE epitope 
For the determination of IgE epitopes, Bla g 4-derived peptides
were expressed as 5 overlapping recombinant peptides E1, E2,
E3, E4, and E5. Four sera showing high level absorbances to
recombinant Bla g 4 were selected for IgE epitope analysis. The
IgE epitope study from Bla g 4-sensitized sera was performed
by ELISA and the results were summarized (Fig. 3). The results
showed that IgE-binding sites were heterogeneously located
among the different sera (Fig. 3A). IgE antibodies from patients
2 and 4 were able to recognize fragments 2 and 4. However,
fragment 3 was recognized only by IgE antibodies of patient 1.
All 4 sera recognized fragment 4. These results indicated that
there were at least 3 IgE-binding antigenic determinants.
DISCUSSION
The IgE-binding reactivity of recombinant Bla g 4 was assessed
by ELISA, and 25% of German cockroach-sensitized Korean
subjects were found to have a positive IgE reactivity to recom-
binant Bla g 4. This prevalence was significantly lower than the
40-60% previously reported by Arruda et al. [1]. Bla g 4 has been
defined as the major allergen in allergic patients, but these results
are in agreement with the results supported by Satinover et al.
(prevalence 17.4%, 7/34) [11] and Slater et al. (prevalence 20.6%,
7/34) [12]. The discrepancies in the IgE-binding reactivity in the
results obtained could be explained by 2 assumptions. One is
to start with minor modifications of the complete molecule by
amino acid substitution. If the modifications cause changes in
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Fig. 2. IgE reactivity of human sera against recombinant Bla g 4.
The horizontal line indicates the cut-off value.     , sera from healthy
controls;     , sera from German cockroach-sensitized subjects (Uni-
CAP > 0.7 kU/L).
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Fig. 3. (A) Binding profiles of IgE antibodies to recombinant Bla g
4 and relevant recombinant proteins by ELISA. 1-4, allergic sera; 5,
pooled sera from healthy controls; 6, bovine serum albumin. The
horizontal line indicates the cut-off value. (B) IgE-binding reactivi-
ties of peptide fragments of German cockroach allergen, Bla g 4.
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the 3-dimensional structure, they could also be expected to affect
the IgE binding. Intramolecular disulfide bridges are a charac-
teristic of lipocalins [13]. Disruption of similar bridges in mite
allergens has been shown to interfere with the IgE binding [14-
17]. Second, the presence of multiple Bla g 4 isoforms in cock-
roach may influence the allergenicity. The presence of multiple
isoforms for other major allergens has also been reported [18].
The isoforms of Birch pollen allergen Bet v 1 and mite allergen
Der p 2, which have 10 and 8 isoforms respectively, were reported
to differ not only in the extent of IgE-binding activity but also
in T-cell activation [18,19].
To determine the IgE-binding epitope, it is necessary to assess
the results of the immunological studies with reference to the
molecular characteristics. Especially, B-cell epitopes are essen-
tial both for the localization of the IgE-binding regions and for
the comparative structural analyses of lipocalin allergens [20].
All the sera tested in this study showed different patterns of IgE-
reactivity. Recently, 3 mutants of Bla g 4 at Arg at 24th amino
acid, Arg at 26th amino acid, and Lys at 75th amino acid, showed
significant reduction in IgE binding in 2 of 24 (8%) sera tested
as compared with wild type protein [21]. This report also implies
the heterogeneous IgE binding of Bla g 4. The results in the pre-
sent study showed that although human IgE antibodies reacted
with antigenic determinants distributed throughout the whole
molecule, a major IgE-binding region was located at residues
118 to 152, close to the C-terminus of Bla g 4. The B-cell epi-
topes of Bos d 5 have been studied mostly using protein frag-
ments, where residues 41 to 60, 102 to 124, and 149 to 162
were identified as the major epitopes [22], a somewhat similar
result in Bla g 4 (Fig. 4). Therefore, comparison between other
allergenic lipocalins needs to be done to determine whether
these epitopes are conserved in other lipocalin allergens. Hetero-
geneity in IgE responses to Bla g 4 in individual patients was
also observed, which correlated with the finding that the most
allergens have multiple IgE-binding sites which is at least partly
the result of the polyclonal nature of the immune response to
protein allergens [23-25]. 
In summary, the predominant variants and allergenicity of
the allergen in different regions can be different. We investigat-
ed the predominant variant and linear IgE binding epitope of
Bla g 4 because of T-cell epitopes of few lipocalin allergens have
been characterized but information of B-cell epitopes have almost
never been known.
Analysis of B-cell epitopes may provide new information for
manipulation of allergens and production of safer forms of spe-
cific immunotherapy with reduced allergenic molecules.
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